Guiraud P, Steiman R, Seigle-Murandi F, Bartoli M H
Groupe pour l'Etude du Devenir des Xénobiotiques dans l'Environnement (GEDEXE), UFR Pharmacie, Meylan, France.
Pharmazie. 1994 Apr;49(4):279-81.
Antifungal, antibacterial and antitumoral properties of 6-allyl-5,6-dihydro-5-hydroxypyran-2-one were researched. This compound was isolated from culture medium of a new Drechslera species from the area of the Dead Sea. The product exhibited a large activity spectrum against microorganisms, with interesting IC 50 values close to those obtained with reference compounds (kanamycin and ketoconazole). Antitumoral potentiality was 10 to 58 times less important than with doxorubicin, however IC 50 obtained were below 4 micrograms/ml, which is the threshold value proposed by National Cancer Institute for preliminary screening of active molecules.
研究了6-烯丙基-5,6-二氢-5-羟基吡喃-2-酮的抗真菌、抗菌和抗肿瘤特性。该化合物是从死海地区一种新的德氏霉属物种的培养基中分离得到的。该产物对微生物表现出广泛的活性谱,其有趣的半数抑制浓度(IC50)值与参考化合物(卡那霉素和酮康唑)相近。然而,其抗肿瘤潜力比阿霉素低10至58倍,不过所获得的IC50低于4微克/毫升,这是美国国立癌症研究所提出的活性分子初步筛选的阈值。